Expert Reaction: FDA Accepts Dupilumab sBLA for CSU
November 20, 2024
U.S. FDA Approves Bimekizumab-bkzx (Bimzelx, UCB) for HS
November 20, 2024
Mindera Health, NPF Partner to Advance Precision Medicine in Psoriasis
November 19, 2024
Celebrate Botox Cosmetic Day
November 19, 2024
Incyte Hits Pause on CSU Trial of MRGPRX2
November 19, 2024
Educational Series
Advertisement
Podcast Series